Company overview
Basic information
Company name
Stamelos medis, UAB
Company code
304989657
VAT code
LT100012214917
Registered address
Šilutė, Šiaurės g. 8, LT-99116
Registration date
2019-01-15
Company age: 7 y. 9 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Website
https://stamelawood.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Manufacture of doors and windows of wood
Ownership form
Private without foreign capital
UAB "Stamelos medis"
Company code: 304989657
Address: Šilutė, Šiaurės g. 8, LT-99116
VAT code: LT100012214917
Description
This description was generated by artificial intelligence.
Stamelos medis, UAB (company code 304989657) is a private limited liability company registered in 2019 and currently operational. It is a privately owned Lithuanian company under private property, with governance described as CEO only. The company is classified as a small national private non-financial enterprise. Its main activity is EVRK C.16.25.00, Manufacture of doors and windows of wood. The company is based in Šilute, Šilutes r. sav., Klaipedos apskr., at Šiaures g. 8, LT-99116. The share capital amounts to EUR 144.4K. In financial year 2025, revenue was EUR 561.8K, down 21.1% year on year and 22.2% over two years. Net profit was negative at EUR 617, with a profit margin of -0.1%. Total assets reached EUR 512.9K, equity stood at EUR 90.0K, and liabilities were EUR 422.9K. The equity ratio was 17.6%. The company employed 15 people on average so far in 2026, compared with 16 in 2025, while average monthly wage reached EUR 1,391.94 so far in 2026, up 4.8% year on year and 33.0% over two years.
Download a detailed company report
Make confident decisions with all the information about Stamelos medis, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.